-
1
-
-
0033670082
-
Vaginal candidosis: Epidemiological and etiological factors
-
Ferrer J: Vaginal candidosis: Epidemiological and etiological factors. Int J Gynaecol Obstet 2000;71:S21-S27
-
(2000)
Int J Gynaecol Obstet
, vol.71
-
-
Ferrer, J.1
-
2
-
-
0037228356
-
Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: Clinical implications
-
Sobel JD, Zervos M, Reed BD, et al: Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: Clinical implications. Antimicrob Agents Chemother 2003;47:34-38
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 34-38
-
-
Sobel, J.D.1
Zervos, M.2
Reed, B.D.3
-
3
-
-
0026028353
-
Fluconazole: A new antifungal agent
-
Kowalsky SF, Dixon DM: Fluconazole: A new antifungal agent. Clin Pharm 1991;10:179-194
-
(1991)
Clin Pharm
, vol.10
, pp. 179-194
-
-
Kowalsky, S.F.1
Dixon, D.M.2
-
4
-
-
0026633205
-
Fluconazole: A potent inhibitor of cytochrome P450-dependent drug-metabolism in mice and humans in vivo: Comparative study with ketoconazole
-
Tokyo
-
Morita K, Konishi H, Shimakawa H: Fluconazole: A potent inhibitor of cytochrome P450-dependent drug-metabolism in mice and humans in vivo: Comparative study with ketoconazole. Chem Pharm Bull (Tokyo) 1992;40:1247-1251
-
(1992)
Chem Pharm Bull
, vol.40
, pp. 1247-1251
-
-
Morita, K.1
Konishi, H.2
Shimakawa, H.3
-
6
-
-
0033807662
-
Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors
-
Henry KW, Nickels JT, Edlind TD: Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother 2000;44:2693-2700
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 2693-2700
-
-
Henry, K.W.1
Nickels, J.T.2
Edlind, T.D.3
-
8
-
-
0033986849
-
The R467K amino acid substitution in Candida albicans sterol 14α-demethylase causes drug resistance through reduced affinity
-
Lamb DC, Kelly DE, White TC, et al: The R467K amino acid substitution in Candida albicans sterol 14α-demethylase causes drug resistance through reduced affinity. Antimicrob Agents Chemother 2000;44:63-67
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 63-67
-
-
Lamb, D.C.1
Kelly, D.E.2
White, T.C.3
-
9
-
-
0031755686
-
Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis
-
Lopez-Ribot JL, McAtee RK, Lee LN, et al: Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother 1998;42:2932-2937
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 2932-2937
-
-
Lopez-Ribot, J.L.1
McAtee, R.K.2
Lee, L.N.3
-
10
-
-
0033836088
-
Transcriptional analyses of antifungal drug resistance in Candida albicans
-
Lyons CN, White TC: Transcriptional analyses of antifungal drug resistance in Candida albicans. Antimicrob Agents Chemother 2000;44:2296-2303
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 2296-2303
-
-
Lyons, C.N.1
White, T.C.2
-
11
-
-
0031687814
-
Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR
-
Marr KA, Lyons CN, Rustad T et al: Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR. Antimicrob Agents Chemother 1998;42:2584-2589
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 2584-2589
-
-
Marr, K.A.1
Lyons, C.N.2
Rustad, T.3
-
12
-
-
0030025637
-
Correlation between rhodamine 123 accumulation and azole sensitivity in Candida spp.: Possible role for drug efflux in drug resistance
-
Clark FS, Parkinson T, Hitchcock CA, et al: Correlation between rhodamine 123 accumulation and azole sensitivity in Candida spp.: Possible role for drug efflux in drug resistance. Antimicrob Agents Chemother 1996;40:419-425
-
(1996)
Antimicrob Agents Chemother
, vol.40
, pp. 419-425
-
-
Clark, F.S.1
Parkinson, T.2
Hitchcock, C.A.3
-
13
-
-
0008837894
-
Lactoferrin
-
Edited by AS Naidu. Boca Raton, Florida, CRC Press.
-
Naidu AS: Lactoferrin. In Natural Food Antimicrobial Systems. Edited by AS Naidu. Boca Raton, Florida, CRC Press. 2000, pp 17-102
-
(2000)
Natural Food Antimicrobial Systems
, pp. 17-102
-
-
Naidu, A.S.1
-
14
-
-
0002349699
-
Influence of lactoferrin on host-microbe interactions
-
Edited by TW Hutchens, B Lönnerdal. Totowa, New Jersey, Humana Press
-
Naidu AS, Arnold RR: Influence of lactoferrin on host-microbe interactions. In Lactoferrin Interactions and Biological Functions. Edited by TW Hutchens, B Lönnerdal. Totowa, New Jersey, Humana Press, 1997, pp 259-275
-
(1997)
Lactoferrin Interactions and Biological Functions
, pp. 259-275
-
-
Naidu, A.S.1
Arnold, R.R.2
-
15
-
-
0028273860
-
Lactoferrin binds to porins OmpF and OmpC in Escherichia coli
-
Erdei J, Forsgren A, Naidu AS: Lactoferrin binds to porins OmpF and OmpC in Escherichia coli. Infect Immun 1994;62:1236-1240
-
(1994)
Infect Immun
, vol.62
, pp. 1236-1240
-
-
Erdei, J.1
Forsgren, A.2
Naidu, A.S.3
-
16
-
-
0027531875
-
Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium
-
Naidu SS, Svensson U, Kishore AR, et al: Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium. Antimicrob Agents Chemother 1993;37:240-245
-
(1993)
Antimicrob Agents Chemother
, vol.37
, pp. 240-245
-
-
Naidu, S.S.1
Svensson, U.2
Kishore, A.R.3
-
17
-
-
0028034634
-
Lactoferrin interaction with salmonellae potentiates antibiotic susceptibility in vitro
-
Naidu AS, Arnold RR: Lactoferrin interaction with salmonellae potentiates antibiotic susceptibility in vitro. Diagn Microbiol Infect Dis 1994;20:69-75
-
(1994)
Diagn Microbiol Infect Dis
, vol.20
, pp. 69-75
-
-
Naidu, A.S.1
Arnold, R.R.2
-
18
-
-
0030457861
-
Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents
-
Wakabayashi H, Abe S, Okutomi T, et al: Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents. Microbiol Immunol 1996;40:821-825
-
(1996)
Microbiol Immunol
, vol.40
, pp. 821-825
-
-
Wakabayashi, H.1
Abe, S.2
Okutomi, T.3
-
19
-
-
0031807119
-
Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds
-
Wakabayashi H, Abe S, Teraguchi S, et al: Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds. Antimicrob Agents Chemother 1998;42:1587-1591
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 1587-1591
-
-
Wakabayashi, H.1
Abe, S.2
Teraguchi, S.3
-
20
-
-
0032707616
-
Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates
-
Kuipers ME, de Vries HG, Eikelboom MC, et al: Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob Agents Chemother 1999;43:2635-2641
-
(1999)
Antimicrob Agents Chemother
, vol.43
, pp. 2635-2641
-
-
Kuipers, M.E.1
De Vries, H.G.2
Eikelboom, M.C.3
-
21
-
-
0036251099
-
Conditions influencing the in vitro antifungal activity of lactoferrin combined with antimycotics against clinical isolates of Candida
-
Kuipers ME, Beljaars L, van Beek N, et al: Conditions influencing the in vitro antifungal activity of lactoferrin combined with antimycotics against clinical isolates of Candida. APMIS 2002;110:290-298
-
(2002)
APMIS
, vol.110
, pp. 290-298
-
-
Kuipers, M.E.1
Beljaars, L.2
Van Beek, N.3
-
22
-
-
0037228719
-
Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species
-
Lupetti A, Paulusma-Annema A, Welling MM, et al: Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species. Antimicrob Agents Chemother 2003;47:262-267
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 262-267
-
-
Lupetti, A.1
Paulusma-Annema, A.2
Welling, M.M.3
-
23
-
-
7244223055
-
-
Immobilized lactoferrin antimicrobial agents and the use. US Patent 6,172,040 B1, 2001
-
Naidu AS: Immobilized lactoferrin antimicrobial agents and the use. US Patent 6,172,040 B1, 2001
-
-
-
Naidu, A.S.1
-
25
-
-
0023815539
-
Damage of the outer membrane of enteric Gram-negative bacteria by lactoferrin and transferring
-
Ellison RT, Giehl TJ, LaForce FM: Damage of the outer membrane of enteric Gram-negative bacteria by lactoferrin and transferring. Infect Immun 1988;56:2774-2781
-
(1988)
Infect Immun
, vol.56
, pp. 2774-2781
-
-
Ellison, R.T.1
Giehl, T.J.2
LaForce, F.M.3
-
26
-
-
0031908759
-
In vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans
-
Barchiesi F, DiFrancesco LF, Compagnucci P, et al: In vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans. J Antimicrob Chemother 1998;41:59-65
-
(1998)
J Antimicrob Chemother
, vol.41
, pp. 59-65
-
-
Barchiesi, F.1
DiFrancesco, L.F.2
Compagnucci, P.3
-
27
-
-
0028839256
-
Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate and propylparaben against Candida albicans in vitro
-
Scott EM, Tariq VN, McCrory RM: Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate and propylparaben against Candida albicans in vitro. Antimicrob Agents Chemother 1995;39:2610-2614
-
(1995)
Antimicrob Agents Chemother
, vol.39
, pp. 2610-2614
-
-
Scott, E.M.1
Tariq, V.N.2
McCrory, R.M.3
-
28
-
-
0036252092
-
Cationic peptides: Distribution and mechanisms of resistance
-
Devine DA, Hancock RE: Cationic peptides: Distribution and mechanisms of resistance. Curr Pharm Des 2002;8:703-714
-
(2002)
Curr Pharm des
, vol.8
, pp. 703-714
-
-
Devine, D.A.1
Hancock, R.E.2
-
29
-
-
0027232811
-
Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin
-
Berl
-
Bellamy W, Wakabayashi H, Takase M, et al: Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med Microbiol Immunol (Berl) 1993;182:97-105
-
(1993)
Med Microbiol Immunol
, vol.182
, pp. 97-105
-
-
Bellamy, W.1
Wakabayashi, H.2
Takase, M.3
-
30
-
-
0026475489
-
Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin
-
Bellamy W, Takase M, Wakabayashi H, et al: Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol 1992;73:472-179
-
(1992)
J Appl Bacteriol
, vol.73
, pp. 472-1179
-
-
Bellamy, W.1
Takase, M.2
Wakabayashi, H.3
|